BMY - Bristol-Myers Squibb Co
301
$58.11
-$1.26 (-2.122%)
At market close
$58.25
$0.14 (0.233%)
After Hours 3/19/26, 11:42 PM
Score3.86/5
Ownership Breakdown
Type | % Ownership | Market Value |
|---|---|---|
Insider | 0.02% | $28.16M |
Institutional | 83.30% | $98.58B |
Common & Other | 16.67% | $19.73B |
Insider Transactions
Buy Transactions
Sell Transactions
Executive Salaries
Name | Compensation | Position(s) | Appointed | Age |
|---|
| Christopher Boerner | $18,787,618 | Chairman of the Board, Chief Executive Officer | 2018 | 54 |
| David Elkins | $8,707,571 | Executive Vice President, Chief Financial Officer, Member of the Leadership Team | 57 | |
| Benjamin Hickey | -- | President - RayzeBio Organization, Member of the Leadership Team | 50 | |
| Lynelle Hoch | -- | President, Cell Therapy Organization, Member of the Leadership Team | 52 | |
| Amanda Poole | -- | Executive Vice President, Chief People Officer, Member of the Leadership Team | 50 | |
| Greg Meyers | -- | Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team | 52 | |
| Cari Gallman | -- | Executive Vice President, General Counsel and Chief Policy Officer | 45 | |
| Adam Lenkowsky | -- | Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team | 52 | |
| Robert Plenge | -- | Executive Vice President, Chief Research Officer, Head of Research, Member of the Leadership Team | 54 | |
| Karin Shanahan | $6,566,581 | Executive Vice President, Global Product Development & Supply, Member of the Leadership Team | 60 | |